Russo Partners

We partner with healthcare and biotechnology companies to navigate critical moments by communicating the science, strategy, and value behind their innovation.

[Russo Partners @russopartners]

The new Russo Partners website is live. Explore our Insights hub, the Russo Edge Podcast, and how we work across media, IR, digital, and strategy to translate complex science into clear stories. https://t.co/awir7zKsKQ

#Biotech #LifeSciences #Healthcare #PR

[Russo Partners @russopartners]

When a high-stakes @US_FDA decision shifted unexpectedly, Russo Partners helped a client respond quickly with expert commentary that shaped early media narratives. The result: A @WSJ placement, broader syndication, and meaningful share of voice. https://t.co/L0w6XZXITt

[Russo Partners @russopartners]

On Russo Edge, @SolomonsWisdom speaks with Dr. Michelle Williams of @StanfordMed and former dean of @HarvardChanSPH about why public health needs both data and human stories to help move policy.

▶️ Interview and video: https://t.co/qZF9DW5FiP
🎙️ Apple Podcasts: https://t.co/HYXLEqoQBw

#Healthcare #PublicHealth #HealthEquity #MaternalHealth #HealthPolicy #Podcast

[Russo Partners @russopartners]

@BioSpace reporter Gabrielle Masson covers renewed momentum in biotech IPOs, with upsized offerings and M&A activity helping shift investor sentiment after a prolonged downturn. Read why the tide may be turning for biotech companies weighing whether to pursue public market access or M&A. https://t.co/SkhQWMEiyw

#LifeSciences #IPO #CapitalMarkets #MandA

[Russo Partners @russopartners]

Healthcare sales does not move on awareness alone. On the Russo Edge, Scott Becker of Becker’s Healthcare joins @SolomonsWisdom to discuss why small and midsize companies need internal champions who see the solution as worth testing and advancing.

💬 Interview: https://t.co/1B4LAvXudh
🎧 Apple Podcasts: https://t.co/k80sJ3KIPF

@BKRBusinessMin @BeckerHR | #Healthcare #Hospitals #Podcast

[Russo Partners @russopartners]

Generating TV and radio mentions across 45 states, a @RussoPartners broadcast and digital media campaign helped a biotech client build national awareness around a regulatory milestone.

Have an important milestone ahead? See how the right strategy can help extend its reach: https://t.co/MII7Aaze1o

#HealthcareCommunications #Biotech #MediaRelations

[Russo Partners @russopartners]

The NFL invests in player health because performance depends on prevention. Why shouldn’t public health be the same?

On Russo Edge, @SolomonsWisdom speaks with Dr. Michelle Williams of @StanfordMed and former dean of @HarvardChanSPH about applying that same mindset to public health.

✔️ Interview and video: https://t.co/qZF9DW5FiP
🎧 Apple Podcasts: https://t.co/HYXLEqoQBw

#Healthcare #PublicHealth #Prevention #HealthEquity #Podcast

[Russo Partners @russopartners]

For years, biotech venture investing followed a formula that worked. Now, that formula is under pressure. @StatNews reporter @ADeAngelis_bio looks at how AI and shifting capital priorities are forcing firms to rethink strategy and compete for investor attention. https://t.co/ZDPcGhxAim

#Biotech #VentureCapital #HealthTech #Innovation

[Russo Partners @russopartners]

mRNA is more than a vaccine technology. It is a strategic platform capability. Tony Russo, Ph.D., of @RussoPartners, shares Board of Advisors insights on why the U.S. risks losing ground in mRNA infrastructure while other countries and global organizations continue moving forward. https://t.co/w5PJDyk05F

#Biotech #mRNA #LifeSciences #Innovation #Leadership

[Russo Partners @russopartners]

Public health works best when we barely notice it. On Russo Edge, @SolomonsWisdom speaks with Dr. Michelle Williams of @StanfordMed and former dean of @HarvardChanSPH about prevention, public health investment, and why health is infrastructure.

✔️ Check out the interview and video: https://t.co/qZF9DW5FiP
🎧 Apple Podcasts: https://t.co/HYXLEqoQBw

#Healthcare #PublicHealth #Prevention #HealthEquity #Podcast

[Russo Partners @russopartners]

Biotech leadership is not maintained by assumption.

Tony Russo, Ph.D., of @RussoPartners, shares part 2 of our Board of Advisors insights on capital concentration, China’s long-term biotech strategy, and the future of mRNA infrastructure in the U.S. https://t.co/Q50FSFA3Lp

#Biotech #LifeSciences #Healthcare #Innovation #Leadership

[Russo Partners @russopartners]

Patients are increasingly going outside traditional hospital and health system channels to access care.

On Russo Edge, @SolomonsWisdom speaks with Scott Becker of Becker's Healthcare about telehealth, GLP-1s, and shifting access models.

✔️ Interview and video: https://t.co/1B4LAvXudh
🎧 Apple Podcasts: https://t.co/k80sJ3KIPF

@BKRBusinessMin @BeckerHR | #Healthcare #Hospitals #Podcast

[Russo Partners @russopartners]

What’s driving pressure on hospitals, and what does it mean for companies working with them?

On Russo Edge, @SolomonsWisdom speaks with Scott Becker of Becker’s Healthcare about hospital access, staffing, reimbursement, tech adoption, and tighter buying decisions.

✔️ Check out the interview and video: https://t.co/1B4LAvXudh
🎧 Apple Podcasts: https://t.co/k80sJ3KIPF

@BKRBusinessMin | #Healthcare #Hospitals #Podcast

[Russo Partners @russopartners]

In Life Science Leader, Mike Carnes of @NCBiotech looks at how emerging life sciences hubs are creating more opportunity for startups and investors beyond the traditional coastal centers.

Read the article: https://t.co/I6WqiQBXcW

#LifeSciences #Biotech #VentureCapital #StartupEcosystem

[Russo Partners @russopartners]

Biotech M&A is becoming more selective. Demand for late-stage assets is rising as companies prepare for loss of exclusivity, but high-quality assets remain scarce. That imbalance is pushing the industry toward more disciplined capital allocation and risk-shared partnerships.

Read the great coverage by @BioXconomy from BIO-Europe Spring in Lisbon. https://t.co/Y4LeCRcuc2

#Biotech #Pharma #MandA

[Russo Partners @russopartners]

Sports media can drive more than awareness. Our @RussoPartners Sports-Health Alliance case study shows how a five-year Super Bowl Radio Row program helped a medical organization expand awareness, connect audiences to care resources, and drive measurable action, with 150+ placements and an 80.5% YoY increase in direct traffic. https://t.co/Q6IUjKExg2

#HealthcareCommunications #MediaRelations #SportsHealth

[Russo Partners @russopartners]

Public health progress wasn’t inevitable; it was built.

@RussoPartners highlights The Cure for Everything by Dr. Michelle A. Williams, showing how prevention drives economic outcomes and why those systems can reverse.
https://t.co/fiFuOymeoq

#PublicHealth #HealthPolicy #Prevention #Leadership

[Russo Partners @russopartners]

Congratulations to Diane L. Martin, MBA, CSSGB on the release of Women in Health, featuring insights from healthcare leaders across the industry. Our own @DavidSchull contributed the foreword.

Explore the book: https://t.co/BemfBoWTGh

#Healthcare #Leadership #WomenInHealth #Biotech #HealthInnovation

[Russo Partners @russopartners]

Trust in public health institutions is becoming a defining issue for biotech. Tony Russo, Ph.D., of @RussoPartners shares insights from our Board of Advisors meeting, including how challenges at @CDCgov are affecting public engagement and confidence. https://t.co/kC3p5PAE50

#PublicHealth #CDC #HealthPolicy #Biotech